Alto Neuroscience, Inc. · NYSE:ANRO
Vestal Point Capital, LP reported a 6.50% stake in Alto Neuroscience, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Vestal Point Capital, LP reported a 6.50% stake in Alto Neuroscience, Inc., 2,064,075 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 6.50%
- Shares
- 2,064,075
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 6.50% | 2,064,075 |
| Ryan Wilder | 6.50% | 2,064,075 |
Source
Related
- Alto Neuroscience, Inc.
- Vestal Point Capital, LP
- Alto Neuroscience, Inc. shareholders
- Schedule 13G/A · Vestal Point Capital, LP · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Feb 17, 2026
- Form 4 · Smith Nicholas Conrad · Oct 5, 2026
- Form 4 · Smith Nicholas Conrad · Oct 1, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026